Meta Biomed Co. Ltd (059210) — Cash Flow-to-Debt Ratio
Meta Biomed Co. Ltd (059210) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of ₩1.05 Billion could theoretically repay 0% of its total liabilities (₩58.87 Billion) in one year. Explore investment intensity of Meta Biomed Co. Ltd to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Meta Biomed Co. Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Meta Biomed Co. Ltd across 14 annual periods. Also explore Meta Biomed Co. Ltd total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Meta Biomed Co. Ltd (2011–2024)
Year-by-year debt coverage analysis for Meta Biomed Co. Ltd. For market capitalisation and broader financial context, see Meta Biomed Co. Ltd (059210) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.27x | ₩22.63 Billion | ₩83.96 Billion | ▲ +51.6% |
| 2023 | 0.18x | ₩10.22 Billion | ₩57.46 Billion | ▲ +17.4% |
| 2022 | 0.15x | ₩9.16 Billion | ₩60.48 Billion | ▼ -39.1% |
| 2021 | 0.25x | ₩11.14 Billion | ₩44.80 Billion | ▲ +206.1% |
| 2020 | 0.08x | ₩4.86 Billion | ₩59.88 Billion | ▲ +41.8% |
| 2019 | 0.06x | ₩2.86 Billion | ₩50.02 Billion | ▲ +151.7% |
| 2018 | -0.11x | ₩-5.28 Billion | ₩47.72 Billion | ▼ -3180.8% |
| 2017 | 0.00x | ₩-248.51 Million | ₩73.65 Billion | ▼ -104.6% |
| 2016 | 0.07x | ₩5.03 Billion | ₩68.49 Billion | ▼ -6.3% |
| 2015 | 0.08x | ₩4.93 Billion | ₩62.91 Billion | ▲ +1975.5% |
| 2014 | 0.00x | ₩-296.24 Million | ₩70.85 Billion | ▼ -108.1% |
| 2013 | 0.05x | ₩3.71 Billion | ₩72.25 Billion | ▼ -16.1% |
| 2012 | 0.06x | ₩3.83 Billion | ₩62.54 Billion | ▼ -77.8% |
| 2011 | 0.28x | ₩4.10 Billion | ₩14.84 Billion | — |